Intersect Ent Gmbh
Patents = 47
Trademarks = 17
Forward Citations = 2,560
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
35 inventors (with patents filed for the assignee):
Intersect ENT GmbH is a biotechnology company focused on providing innovative solutions for patients with ear, nose, and throat (ENT) conditions. With a mission to improve the quality of life for patients suffering from chronic sinusitis, Intersect ENT GmbH develops and commercializes advanced products that enable minimally invasive treatments. Their flagship product, PROPEL sinus stent, helps maintain sinus openings and improve post-surgical outcomes. Intersect ENT GmbH is committed to advancing the treatment options available to ENT specialists and providing relief to patients.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com